Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Comment by eSnowdenon Apr 26, 2020 5:56pm

148 Views

Post# 30955540

RE:RE:Transcript of Q4 Earnings Conference

Q&A was a good one. Looks like Q1 2020 will be another Q4 2019, according to the conference call. Might explain the bottomless selling. The CEO didn't really answer if the coronavirus was negatively impacting sales. Those reported trial results from Dec. should be released soon. Overall, the current state of operations is pretty darn depressing.

Bullboard Posts

A PGM mining stock with value written all over it